ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
SPDR S&P Biotech ETF
156.20
-0.6200
-0.40%
盤後:
156.43
0.2300
+0.15%
19:59 EDT
成交量:
841.39萬
成交額:
13.25億
市值:
105.24億
市盈率:
8.57
高:
159.66
開:
158.27
低:
156.13
收:
156.82
52周最高:
169.89
52周最低:
92.64
股本:
6,737.50萬
流通股本:
6,737.50萬
量比:
1.28
換手率:
12.49%
股息:
0.56
股息率:
0.36%
每股收益(TTM):
18.23
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞
公告
健康160(02656)開展醫療健康與AI算力融合新業務
智通财经
·
2小時前
商業化放量疊加管線兑現 科創板生物醫藥企業進入收穫期
经济参考网
·
昨天
推動AI與醫療健康融合發展 三項合作亮相服貿會
经济参考网
·
昨天
邕寧區企業參與項目榮獲廣西科學技術進步獎一等獎
邕宁发布
·
昨天
政策解答!事關泰興職工醫保退休待遇
泰兴发布
·
昨天
醫療保健板塊市場綜述:諾華、樂敦、手套製造業與IHH等熱點解析
投资观察
·
09/12
醫療保健板塊動態:市場快訊綜述
投资观察
·
09/12
內蒙古:圍繞生物食品、生物醫藥、生物化工等重點領域 加快實施生物製造產業重點項目
格隆汇
·
09/11
醫療保健板塊動態:市場快訊綜述
投资观察
·
09/11
百龍創園在昆明成立生物科技公司
智通财经
·
09/11
美國總統特朗普:我們將直接向美國人發放資金,用於購買醫療保險,並讓他們保留剩餘部分。
格隆汇
·
09/11
健康產業綜合報道:市場快訊
投资观察
·
09/11
醫療保健板塊市場綜述:多空交織下的投資機遇
投资观察
·
09/11
醫療保健板塊市場快訊綜述
投资观察
·
09/10
國泰海通證券累計投資超60家生物醫藥優質企業,投資總規模突破35億元
南方财经网
·
09/10
傳私募股權TPG(TPG.US)擬出售醫療保健軟件公司Lyric 估值或達50億美元
智通财经
·
09/10
傳私募股權TPG(TPG.US)擬出售醫療保健軟件公司Lyric 估值或達50億美元
智通财经
·
09/10
TPG考慮以50億美元出售醫療保健軟件公司Lyric
格隆汇
·
09/10
TPG探索出售醫療保健軟件公司Lyric
智通财经
·
09/10
醫療板塊市場綜述:多空觀點交鋒
投资观察
·
09/10
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/XBI/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":156.2,"timestamp":1789156800000,"preClose":156.82,"halted":0,"volume":8413893,"hourTrading":{"tag":"盘后","latestPrice":156.43,"preClose":156.2,"latestTime":"19:59 EDT","volume":555911,"amount":86836947.7522,"timestamp":1789171191129,"change":0.23,"changeRate":0.001472,"amplitude":0.001601},"delay":0,"changeRate":-0.0039535773498278574,"floatShares":67375000,"shares":67375000,"eps":18.23,"marketStatus":"休市中","change":-0.62,"latestTime":"09-11 16:00:00 EDT","open":158.27,"high":159.6607,"low":156.13,"amount":1324607084.0494199,"amplitude":0.022514,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":156.82,"sharesOutstanding":63325000,"nav":156.174274,"aum":10736981366.38,"dividendRate":0.003615,"bidAskSpread":0.000302,"preHourTrading":{"tag":"盘前","latestPrice":158.23,"preClose":156.82,"latestTime":"09:29 EDT","volume":40501,"amount":6393566.4319400005,"timestamp":1789133399999,"change":1.41,"changeRate":0.008991,"amplitude":0.013009},"postHourTrading":{"tag":"盘后","latestPrice":156.43,"preClose":156.2,"latestTime":"19:59 EDT","volume":555911,"amount":86836947.7522,"timestamp":1789171191129,"change":0.23,"changeRate":0.001472,"amplitude":0.001601},"volumeRatio":1.2777409531718278,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1790308800000,"strike":"157.0","timestamp":1789148514638,"price":3.65,"volume":2865,"amount":1045725,"type":"+"},{"symbol":"XBI","call":false,"expireDate":1790308800000,"strike":"150.0","timestamp":1789148514638,"price":1.15,"volume":2865,"amount":329475,"type":"-"}]},"impliedVol":0.2874,"impliedVolPercentile":0.1554},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":67375000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.2777409531718278,"shares":67375000,"dividePrice":0.5646,"high":159.6607,"amplitude":0.022514,"preClose":156.82,"low":156.13,"week52Low":92.64,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":156.2,"eps":18.23,"divideRate":0.003615,"volume":8413893,"delay":0,"ttmEps":18.23,"open":158.27,"prevYearClose":121.93,"prevWeekClose":163.81,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":164.38,"twentyDayClose":156.86,"sixtyDayClose":135.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667312635","title":"健康160(02656)開展醫療健康與AI算力融合新業務","url":"https://stock-news.laohu8.com/highlight/detail?id=2667312635","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667312635?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 07:11","pubTimestamp":1789341110,"startTime":"0","endTime":"0","summary":"董事会认为,该解决方案的顺利交付与验收,是本集团在医疗健康与AI算力融合领域新业务路径的重要探索与关键突破节点。本集团注意到,随着AI技术对医疗健康行业应用的不断深入,持续提升,下游客户对“AI应用+算力基础设施”一体化交付的需求正逐步释放。尤其在智能穿戴健康监测、慢病管理等场景中,AI软件平台与算力基础设施的协同部署已成为医疗健康类企业客户实现业务闭环的关键环节。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495390.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","WISE","BK4550","AIO","XBI","02656","BK1197","VHT","WDAI","XLV","BK4581","LABU","BK4588","159760","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667568232","title":"商業化放量疊加管線兑現 科創板生物醫藥企業進入收穫期","url":"https://stock-news.laohu8.com/highlight/detail?id=2667568232","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667568232?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 20:10","pubTimestamp":1789301423,"startTime":"0","endTime":"0","summary":"2026年半年度财报季已收官,在创新药企业以业绩扭亏和BD兑现吸引市场目光的同时,以CXO为代表的上游服务企业正走出周期低谷,单抗、双抗、ADC等核心管线也在临床推进与新增适应症落地中持续兑现价值,勾勒出科创板生物医药企业基本盘企稳、新动能蓄力的图景。创新药企业核心产品持续放量,商业化与国际化双轮驱动业绩改善。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609133872861973.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609133872861973.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","BK4585","BK4581","XBI","KSTR","399441","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667686879","title":"推動AI與醫療健康融合發展 三項合作亮相服貿會","url":"https://stock-news.laohu8.com/highlight/detail?id=2667686879","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667686879?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 11:50","pubTimestamp":1789271434,"startTime":"0","endTime":"0","summary":"日前,2026年中国国际服务贸易交易会(下称“服贸会”)昌平交易分团举办2026国际健康与环境产业发展系列活动暨中欧跨境产业合作交流会。会上,北京清华长庚医院、北京华医智锦健康科技集团(下称“华医智锦集团”)等开展的“两体融合智联中枢”天健平台启动,AI健康联合研发中心揭牌,AI健康与智联中枢首批协同合作战略协议签署等三项AI健康合作集中亮相。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609133872792846.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609133872792846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ARTY","159760","AGIX","BK4585","BK4588","IXJ","VTHR","LABU","BK4581","CHAT","AIPO","QTOC","XBI","XLV","VHT","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667685237","title":"邕寧區企業參與項目榮獲廣西科學技術進步獎一等獎","url":"https://stock-news.laohu8.com/highlight/detail?id=2667685237","media":"邕宁发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667685237?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 11:07","pubTimestamp":1789268820,"startTime":"0","endTime":"0","summary":"近日,在广西科学技术奖励评选中,由广西医科大学第一附属医院曹存巍教授牵头,广西鹤兰墨广泽生物科技有限公司协同参与的“广西(东盟)重大真菌病精准诊疗与防控关键技术集成及产业化”项目,荣获广西科学技术进步奖一等奖。此次殊荣的获得,是广西鹤兰墨广泽生物科技有限公司长期坚持产学研深度融合发展的成果体现。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-13/doc-inirrxsc0620132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","MEDX","SYNB","BK4585","BK4581","AGNG","GDOC","IBBJ","IEIH","BK4588","LNGR","HBImain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667851836","title":"政策解答!事關泰興職工醫保退休待遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2667851836","media":"泰兴发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667851836?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 10:31","pubTimestamp":1789266660,"startTime":"0","endTime":"0","summary":"我市职工医保退休待遇核定政策解答来了一办理医保退休待遇核定需达到哪些条件?举个例子:2026年泰兴一单位男职工,已交200个月,缴费基数4952元,那么他办理退休时需一次性补缴的医疗保险费用为*10%*4952=49520元;如他有2 年的视同缴费年限,那么他办理退休时需一次性补缴的医疗保险费用为*10%*4952=37635.20元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-13/doc-inirrxsc0610142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XLV","BK4585","XBI","BK4588","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147535317","title":"醫療保健板塊市場綜述:諾華、樂敦、手套製造業與IHH等熱點解析","url":"https://stock-news.laohu8.com/highlight/detail?id=1147535317","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147535317?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:56","pubTimestamp":1789160215,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场快讯速览——本系列报道聚焦于行业动态,为您捕捉关键信息。0110 ET - 野村证券分析报告称,得益于核心品牌在日本及海外市场的强劲销售势头,乐敦制药本财年业绩有望超越其全年指引。花旗预计,这家医疗器械制造商\"中期内可实现可持续的两位数盈利增长,且相比澳新其他医疗股,受消费端波动的影响更小。该股当前下跌1.3%,报43.37新西兰元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","BK4588","BK4585","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183095065","title":"醫療保健板塊動態:市場快訊綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1183095065","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183095065?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 00:22","pubTimestamp":1789143768,"startTime":"0","endTime":"0","summary":"最新一期的医疗保健行业市场快讯已发布,涵盖多家业内重要企业的动态。本综述仅在道琼斯通讯社于美东时间4:20、12:20及16:50独家刊出。美东时间1930 - 花旗对斐雪派克医疗持看多立场,认为该公司为投资者提供了增长性与交付可靠性兼备的投资标的。花旗预计,这家医疗器械制造商“中期内将实现可持续的两位数盈利增长,且相较澳新地区其他医疗类股票,其对消费端波动的敞口更低”。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XLV","BK4588","BK4585","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666540291","title":"內蒙古:圍繞生物食品、生物醫藥、生物化工等重點領域 加快實施生物製造產業重點項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2666540291","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666540291?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 17:19","pubTimestamp":1789118364,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["399441","XBI","BK4585","BK4588","BK4581","159151","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139785537","title":"醫療保健板塊動態:市場快訊綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1139785537","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139785537?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 16:23","pubTimestamp":1789115000,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场快讯,涵盖多只个股动态与行业趋势。这些信息分别在美东时间4:20、12:20和16:50通过道琼斯通讯社独家发布。2330 GMT——费雪派克医疗保健获得花旗的看涨背书,后者认为该公司既能提供增长潜力,又具备可靠的业绩兑现能力。花旗预计这家医疗器械制造商“中期内将实现可持续的两位数盈利增长,且相较于澳新地区的其他医疗保健类股票,其对消费者动态的敞口较低。”该股现报43.37新西兰元,下跌1.3%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","BK4585","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666510878","title":"百龍創園在昆明成立生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2666510878","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666510878?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 10:32","pubTimestamp":1789093959,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","GDOC","IEIH","BK4585","XBI","LNGR","MEDX","SYNB","BK4588","IBBJ","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666517011","title":"美國總統特朗普:我們將直接向美國人發放資金,用於購買醫療保險,並讓他們保留剩餘部分。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666517011","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666517011?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 10:28","pubTimestamp":1789093737,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["XBI","BK4585","BK4581","XLV","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114631909","title":"健康產業綜合報道:市場快訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1114631909","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114631909?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 04:52","pubTimestamp":1789073579,"startTime":"0","endTime":"0","summary":"最新一期聚焦健康产业的市场快讯,于美东时间4:20、12:20及16:50通过道琼斯通讯社首发。当日,该公司股价下滑4.2%,收于8.72港元。马来西亚橡胶产品行业的盈利动能似乎正趋于稳定,而近年来股价的大幅回调使得估值更具吸引力,兴业投行分析师Andrew Lim在一份报告中如此表示。有鉴于此,兴业投行将该国橡胶产品行业的评级从“减持”上调至“增持”,并将贺特佳视为其首选标的。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","XLV","XBI","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110355096","title":"醫療保健板塊市場綜述:多空交織下的投資機遇","url":"https://stock-news.laohu8.com/highlight/detail?id=1110355096","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110355096?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 00:22","pubTimestamp":1789057364,"startTime":"0","endTime":"0","summary":"最新一轮医疗保健板块市场动态已出炉,涵盖多家亚洲主要医疗企业的股价走势、业绩展望与投资评级调整。市场反应方面,该股当日下跌4.2%,报收8.72港元。综合来看,亚洲医疗健康领域正呈现出多元化的投资叙事:从中国药企的临床数据催化,到新加坡医疗运营商的估值修复逻辑,再到印度医院的扩张故事以及马来西亚橡胶制品板块的估值重估,各细分赛道均蕴藏着不同的机遇与挑战。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4581","LABU","XBI","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143873044","title":"醫療保健板塊市場快訊綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1143873044","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143873044?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 16:23","pubTimestamp":1789028599,"startTime":"0","endTime":"0","summary":"DBS集团研究部的Mark Kong与Nico Chen在一份报告中指出,石药集团未来两个月即将公布的临床数据演示,可能成为其股价近期走势的关键催化剂。分析师认为,公司主动参与数据发布,彰显了其对数据的充分信心。目前石药集团的估值约为2027年预测市盈率的18倍,较同行平均水平折价约28%,这为投资者提供了一个颇具吸引力的入场时机。DBS重新覆盖石药集团,给予\"买入\"评级,目标价定为13.70港元。该股今日下跌4.2%,报8.72港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4588","BK4581","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666655765","title":"國泰海通證券累計投資超60家生物醫藥優質企業,投資總規模突破35億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666655765","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666655765?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 13:08","pubTimestamp":1789016880,"startTime":"0","endTime":"0","summary":"南方财经9月10日电,9月8日至9日,国泰海通2026上海国际医药健康创新与资本大会暨第15届医药CEO论坛在上海召开。国泰海通党委书记、董事长朱健在致辞中表示,国泰海通持续构建“投资+投行+投研”三投联动的立体化服务体系,深度覆盖生物医药企业全生命周期,以一站式综合金融服务,精准匹配产业发展与企业成长的多元需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609103870433953.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609103870433953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["399441","BK0012","BK0201","BK1564","02611","XBI","PRTO","161726","BK4588","03441","BK0183","161027","BK0188","601211","BK0028","BK0276","BK4585","BK0184","BK4581","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666554879","title":"傳私募股權TPG(TPG.US)擬出售醫療保健軟件公司Lyric 估值或達50億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666554879","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666554879?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 10:30","pubTimestamp":1789007455,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","CGVV","LABU","NOBL","XLV","XBI","BK4550","IGM","AAUM","PRVT","BUYO","PSP","BK4581","BK4588","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666554821","title":"傳私募股權TPG(TPG.US)擬出售醫療保健軟件公司Lyric 估值或達50億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666554821","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666554821?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 10:30","pubTimestamp":1789007455,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,据知情人士透露,私募股权TPG正在探索出售医疗保健行业软件公司Lyric。他们提醒称,目前无法保证出售流程最终会促成Lyric交易。TPG于2022年以约22亿美元收购ClaimsXten。TPG于次年将该公司重新命名为Lyric。尽管具体增幅并未披露,但TPG表示,Lyric受益于AI的部署,而其拥有丰富数据集的业务模式将进一步放大这些收益。规模较小的上市同行Claritev股价在2025年9月至今年5月期间暴跌80%,原因是投资者担心AI会颠覆软件公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494262.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XBI","BK4588","CGVV","LABU","VHT","BUYO","BK4581","BK4585","IGM","PRVT","PSP","NOBL","BK4550","AAUM","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666955978","title":"TPG考慮以50億美元出售醫療保健軟件公司Lyric","url":"https://stock-news.laohu8.com/highlight/detail?id=2666955978","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666955978?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 09:48","pubTimestamp":1789004922,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["VHT","XLV","BK4585","IGM","CGVV","XBI","NOBL","BK4588","LABU","BK4550","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666553284","title":"TPG探索出售醫療保健軟件公司Lyric","url":"https://stock-news.laohu8.com/highlight/detail?id=2666553284","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666553284?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 07:38","pubTimestamp":1788997084,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VHT","LABU","XBI","BK4585","NOBL","CGVV","BK4550","BK4581","XLV","IGM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123618563","title":"醫療板塊市場綜述:多空觀點交鋒","url":"https://stock-news.laohu8.com/highlight/detail?id=1123618563","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123618563?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 04:53","pubTimestamp":1788987194,"startTime":"0","endTime":"0","summary":"最新一期医疗板块市场快讯已发布,涵盖多家制药巨头的最新动态与分析师观点。本轮快讯于美国东部时间4:20、12:20和16:50在道琼斯通讯社独家刊出。**1107 ET**——加拿大皇家银行资本市场分析师在研报中指出,近期临床试验受挫意味着诺华制药必须在剩余管线产品的市场推广上做到近乎完美,抑或寻求并购交易。RBC给予该股\"与板块持平\"评级,目标价定为120瑞士法郎。诺华股价微跌0.3%,报111.44法郎。协和麒麟周二表示,该研究未能达到主要终点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XLV","BK4588","XBI","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}